Jonathan Herskovitz

3.2k citations
25 papers · 2.5k · 2 hit papers · h-index 17

Impact in

    • SARS-CoV-2 detection and testing
    • SARS-CoV-2 and COVID-19 Research
    • COVID-19 Clinical Research Studies
  • Virology top 5%
    • HIV Research and Treatment

Papers in

    • SARS-CoV-2 and COVID-19 Research 4
    • COVID-19 Clinical Research Studies 2
    • HIV/AIDS drug development and treatment 2
    • Nanoparticle-Based Drug Delivery 5

Jonathan Herskovitz

24 papers receiving 2.5k citations

Jonathan Herskovitz's Hit Papers

Diagnostics for SARS-CoV-2 infections 2021 · 650 citations
6500+4+8Years since publication200400600

Peers

Jonathan Herskovitz
Comparison fields: 5 of 134
  • Infectious Diseases 767
  • Virology 130
  • Immunology 569
  • Neurology 118
  • Pharmaceutical Science 68
Replace Shuaiyao Lu with:
Shuaiyao Lu China
Wenhai Yu China
Luca Varani Switzerland
Jing Xue China
Paulo J.C. Lin United States
Kaili Wu China
Yun Yang China
José Ángel Regla-Nava United States
Henry Koziel United States
Jakob Loschko United States
Jonathan Herskovitz relative to Shuaiyao Lu China Shuaiyao Lu's profile →
Citations per field
00.5×2×4×6.1×
Shuaiyao Lu · 1×
Citations per year

Countries citing papers authored by Jonathan Herskovitz

Since Specialization
Citations

This map shows the geographic impact of Jonathan Herskovitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Herskovitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Herskovitz more than expected).

Fields of papers citing papers by Jonathan Herskovitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Herskovitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Herskovitz. The network helps show where Jonathan Herskovitz may publish in the future.

Co-authors

The 25 scholars most cited alongside Jonathan Herskovitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jonathan Herskovitz Line = papers co-authored together Jonathan Herskovitz links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Diagnostics for SARS-CoV-2 infections
Hit paper breakdown →
2021650
2
Blockade of Chronic Type I Interferon Signaling to Control Persistent LCMV Infection
Hit paper breakdown →
2013614
3 2020434
4 2021115
5 2020106
6 2016102
7 202184
8 201683
9 201658
10 202145
11 202145
12 201839
13 201930
14 201928
15 201927
16 201924
17 201918
18 202414
19 201710
20 20219

About Jonathan Herskovitz

Jonathan Herskovitz is a scholar working on Infectious Diseases, Biomaterials, Immunology, Pharmaceutical Science and Virology, having authored 25 papers that have together received 2.5k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Advanced Drug Delivery Systems (3 papers), Biosimilars and Bioanalytical Methods (3 papers), COVID-19 Clinical Research Studies (2 papers), Alzheimer's disease research and treatments (2 papers), HIV Research and Treatment (2 papers) and HIV/AIDS drug development and treatment (2 papers). The work is most often cited by research in Infectious Diseases (767 citations), Virology (130 citations), Immunology (569 citations), Neurology (118 citations) and Pharmaceutical Science (68 citations). Jonathan Herskovitz has collaborated with scholars based in United States, India and China. Frequent co-authors include Howard Eliot Gendelman, Bhavesh D. Kevadiya, Jatin Machhi, David G. Brooks, Elizabeth B. Wilson, Heidi J. Elsaesser, Mahmudul Hasan, Christopher L. Karp, Genhong Cheng and Douglas H. Yamada. Their work appears in journals such as Journal of Neuroimmune Pharmacology, Biomaterials, Journal of Controlled Release, Oncotarget and Journal of Neuroinflammation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact